BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25268743)

  • 1. HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs.
    Esposito F; De Martino M; Petti MG; Forzati F; Tornincasa M; Federico A; Arra C; Pierantoni GM; Fusco A
    Oncotarget; 2014 Sep; 5(18):8341-54. PubMed ID: 25268743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGA1-pseudogene expression is induced in human pituitary tumors.
    Esposito F; De Martino M; D'Angelo D; Mussnich P; Raverot G; Jaffrain-Rea ML; Fraggetta F; Trouillas J; Fusco A
    Cell Cycle; 2015; 14(9):1471-5. PubMed ID: 25894544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of
    De Martino M; Palma G; Arra C; Chieffi P; Fusco A; Esposito F
    Cell Cycle; 2020 Sep; 19(18):2281-2285. PubMed ID: 32787507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA1P7-pseudogene regulates H19 and Igf2 expression by a competitive endogenous RNA mechanism.
    De Martino M; Forzati F; Marfella M; Pellecchia S; Arra C; Terracciano L; Fusco A; Esposito F
    Sci Rep; 2016 Nov; 6():37622. PubMed ID: 27874091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGA1-pseudogene overexpression contributes to cancer progression.
    Esposito F; De Martino M; Forzati F; Fusco A
    Cell Cycle; 2014; 13(23):3636-9. PubMed ID: 25483074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HMGA1 Pseudogene 7 Induces miR-483 and miR-675 Upregulation by Activating Egr1 through a ceRNA Mechanism.
    De Martino M; Palma G; Azzariti A; Arra C; Fusco A; Esposito F
    Genes (Basel); 2017 Nov; 8(11):. PubMed ID: 29149041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGA1-pseudogene7 transgenic mice develop B cell lymphomas.
    De Martino M; De Biase D; Forzati F; Credendino SC; Palma G; Barbieri A; Arra C; Paciello O; Gaudio E; Ponzoni M; De Vita G; Chieffi P; Bertoni F; Fusco A; Esposito F
    Sci Rep; 2020 Apr; 10(1):7057. PubMed ID: 32341372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2.
    Tian X; Song J; Zhang X; Yan M; Wang S; Wang Y; Xu L; Zhao L; Wei JJ; Shao C; Kong B; Liu Z
    Cell Death Dis; 2020 Mar; 11(3):167. PubMed ID: 32127525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of small interfering RNA specific to stably transfected HMGA1 gene on biological characters of ovarian carcinoma cells].
    Liu YL; Zheng JH
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):51-5. PubMed ID: 20367927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGA2, but not HMGA1, is overexpressed in human larynx carcinomas.
    Palumbo A; De Martino M; Esposito F; Fraggetta F; Neto PN; Valverde Fernandes P; Santos IC; Dias FL; Nasciutti LE; Meireles Da Costa N; Fusco A; Ribeiro Pinto LF
    Histopathology; 2018 Jun; 72(7):1102-1114. PubMed ID: 29266325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs.
    D'Angelo D; Mussnich P; Rosa R; Bianco R; Tortora G; Fusco A
    BMC Cancer; 2014 Nov; 14():851. PubMed ID: 25409711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes.
    Chiefari E; Iiritano S; Paonessa F; Le Pera I; Arcidiacono B; Filocamo M; Foti D; Liebhaber SA; Brunetti A
    Nat Commun; 2010 Jul; 1():40. PubMed ID: 20975707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells.
    Orlandella FM; Di Maro G; Ugolini C; Basolo F; Salvatore G
    Oncotarget; 2016 Oct; 7(43):70575-70588. PubMed ID: 27661106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA let‑7d‑5p rescues ovarian cancer cell apoptosis and restores chemosensitivity by regulating the p53 signaling pathway via HMGA1.
    Chen YN; Ren CC; Yang L; Nai MM; Xu YM; Zhang F; Liu Y
    Int J Oncol; 2019 May; 54(5):1771-1784. PubMed ID: 30816441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid Follicular Cell Loss of Differentiation Induced by MicroRNA miR-17-92 Cluster Is Attenuated by CRISPR/Cas9n Gene Silencing in Anaplastic Thyroid Cancer.
    Fuziwara CS; Saito KC; Kimura ET
    Thyroid; 2020 Jan; 30(1):81-94. PubMed ID: 31578932
    [No Abstract]   [Full Text] [Related]  

  • 16. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis.
    Palmieri D; D'Angelo D; Valentino T; De Martino I; Ferraro A; Wierinckx A; Fedele M; Trouillas J; Fusco A
    Oncogene; 2012 Aug; 31(34):3857-65. PubMed ID: 22139073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β1 induces HMGA1 expression in human breast cancer cells: implications of the involvement of HMGA1 in TGF-β signaling.
    Zu X; Zhong J; Tan J; Tan L; Yang D; Zhang Q; Ding W; Liu W; Wen G; Liu J; Cao R; Jiang Y
    Int J Mol Med; 2015 Mar; 35(3):693-701. PubMed ID: 25572132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas.
    Wang Y; Hardin H; Chu YH; Esbona K; Zhang R; Lloyd RV
    Endocr Pathol; 2019 Dec; 30(4):262-269. PubMed ID: 31468286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-Mediated Regulation of HMGA1 Function.
    Benecke AG; Eilebrecht S
    Biomolecules; 2015; 5(2):943-57. PubMed ID: 26117853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells.
    Kitchen MO; Yacqub-Usman K; Emes RD; Richardson A; Clayton RN; Farrell WE
    Pituitary; 2015 Oct; 18(5):674-84. PubMed ID: 25557289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.